Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Celleration Inc.

This article was originally published in Start Up

Executive Summary

There are four pillars of chronic wound care, and few products address all of them satisfactorily. The four factors encouraging wound healing include debridement, bacterial management, increased blood circulation, and the stimulation of healthy cells. Celleration believes it has all four requirements covered with its MIST Therapy System ultrasound device for wound healing.
Advertisement

Related Content

Wound Care: Medtech's New Billion Dollar Product Market
Advanced Wound Care: The Device Industry's New Billion Dollar Product Market
Salve for the Wound Care Market

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT037350

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel